MET kinase-IN-3

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

MET kinase-IN-3 

MET kinase-IN-3 (compound 8) 是一种口服有效的 MET 抑制剂，其 IC50 为9.8 nM。MET kinase-IN-3 对癌细胞具有良好的广谱抗增殖活性。

MET kinase-IN-3

MET kinase-IN-3 Chemical Structure

CAS No. : 1446324-02-2

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

MET kinase-IN-3 (compound 8) is an orally active and potent MET inhibitor, with an IC50 of 9.8 nM. MET kinase-IN-3 shows good and broad-spectrum antiproliferative activity against cancer cell lines[1].

IC50 & Target

MET

9.8 nM (IC50)

VEGFR2

68 nM (IC50)

分子量

491.88

Formula

C25H16ClF2N5O2
CAS 号

1446324-02-2
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Wang MS, et al. Synthesis and biological evaluation of new MET inhibitors with 1,6-naphthyridinone scaffold. Eur J Med Chem. 2020 Jan 1;185:111803.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务